Francis Medical Launches with $18M Series A Funding for Promising Cancer Ablation Technology Using Water Vapor

Francis Medical, Inc., a Minneapolis-based, privately held medical device company developing an innovative and proprietary vapor ablation therapy to treat a variety of endourology cancers, beginning with Prostate Cancer (PCa), today announced the completion of a $18.0 million round of Series A financing.